Bioequivalence and Bioavailability Forum • ABE for partial replicate design acc. to the FDA

ABE for partial replicate design acc. to the FDA [RSABE / ABEL]

posted by Nirali – India, 2026-02-18 13:04 (123 d 13:46 ago) – Posting: # 24576
Views: 1,162
(edited on 2026-02-19 04:57)

Hello Helmut,
Have you got a chance to work on it later?
Have a great Day :-)

:-)

—
Nirali Mehta
(PHARMA-STATS)

Complete thread:

Simulation of inter-subject variability in replicate study Shuanghe 2025-12-14 17:35 [RSABE / ABEL]
- Simulation of inter-subject variability in replicate study mittyri 2025-12-18 14:07
  - Simulation of inter-subject variability in replicate study Shuanghe 2025-12-30 10:22
    - ABE for partial replicate design acc. to the FDA Helmut 2025-12-30 11:11
      - ABE for partial replicate design acc. to the FDANirali 2026-02-18 12:04

Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
142 visitors (0 registered, 142 guests [including 38 identified bots]).
Forum time: 03:50 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door. Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz